Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

  • ID: 4278259
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Theravance Biopharma
1 of 5


  • Allergan Plc
  • Allergy Therapeutics Plc
  • GlaxoSmithKline Plc
  • GW Pharmaceuticals Plc
  • Merck & Co Inc
  • MORE

Theravance Biopharma Inc (Theravance Biopharma) is a diversified biopharmaceutical company that discovers and develops novel medicines for the treatment of various diseases. the company's product include telavancin, which is a dual mechanism antibiotic. Its pipeline programs include Revefenacin, a long-acting muscarinic antagonist which is being developed as a potential once-daily, nebulized treatment for chronic obstructive pulmonary disease and neprilysin inhibitor program is designed to develop selective NEP inhibitors for the treatment of cardiovascular and renal diseases. The company develops product candidates for various therapeutic areas such as respiratory, cardiovascular, gastrointestinal, and infectious diseases. It has presence in the US, Cayman Islands, and Ireland. Theravance is headquartered in George Town, the UK.

Theravance Biopharma Inc Key Recent Developments

Feb 27, 2018: Theravance Biopharma Announces Fourth Quarter and Full Year 2017 Financial Results
Nov 07, 2017: Theravance Biopharma Reports Third Quarter 2017 Financial Results and Provides Business Update
Nov 01, 2017: Theravance Biopharma Announces Opening of Company's New Corporate Office in Dublin, Ireland
Aug 08, 2017: Theravance Biopharma Reports Second Quarter 2017 Financial Results and Provides Business Update
Jul 31, 2017: Theravance Biopharma Appoints Shehnaaz Suliman, MD, as Senior Vice President of Corporate Development and Strategy

This comprehensive SWOT profile of Theravance Biopharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Theravance Biopharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5


  • Allergan Plc
  • Allergy Therapeutics Plc
  • GlaxoSmithKline Plc
  • GW Pharmaceuticals Plc
  • Merck & Co Inc
  • MORE
Section 1 - About the Company
  • Theravance Biopharma Inc - Key Information
  • Theravance Biopharma Inc - Overview
  • Theravance Biopharma Inc - Key Employees
  • Theravance Biopharma Inc - Key Employee Biographies
  • Theravance Biopharma Inc - Key Operational Heads
  • Theravance Biopharma Inc - Major Products and Services
  • Theravance Biopharma Inc - History
  • Theravance Biopharma Inc - Company Statement
  • Theravance Biopharma Inc - Locations And Subsidiaries
  • Theravance Biopharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Theravance Biopharma Inc - Business Description
  • Theravance Biopharma Inc - Corporate Strategy
  • Theravance Biopharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Theravance Biopharma Inc - Strengths
  • Theravance Biopharma Inc - Weaknesses
  • Theravance Biopharma Inc - Opportunities
  • Theravance Biopharma Inc - Threats
  • Theravance Biopharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Theravance Biopharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Theravance Biopharma Inc, Key Information
  • Theravance Biopharma Inc, Key Ratios
  • Theravance Biopharma Inc, Share Data
  • Theravance Biopharma Inc, Major Products and Services
  • Theravance Biopharma Inc, History
  • Theravance Biopharma Inc, Key Employees
  • Theravance Biopharma Inc, Key Employee Biographies
  • Theravance Biopharma Inc, Key Operational Heads
  • Theravance Biopharma Inc, Other Locations
  • Theravance Biopharma Inc, Subsidiaries
  • Theravance Biopharma Inc, Key Manufacturing facilities
  • Theravance Biopharma Inc, Key Competitors
  • Theravance Biopharma Inc, SWOT Analysis
  • Theravance Biopharma Inc, Ratios based on current share price
  • Theravance Biopharma Inc, Annual Ratios
  • Theravance Biopharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Theravance Biopharma Inc, Performance Chart
  • Theravance Biopharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Merck & Co Inc
  • GW Pharmaceuticals Plc
  • GlaxoSmithKline Plc
  • Allergy Therapeutics Plc
  • Allergan Plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown